Annual FCF
-$52.01 M
+$28.23 M+35.18%
December 31, 2022
Summary
- As of February 10, 2025, SGTX annual free cash flow is -$52.01 million, with the most recent change of +$28.23 million (+35.18%) on December 31, 2022.
- During the last 3 years, SGTX annual FCF has fallen by -$728.00 thousand (-1.42%).
Performance
SGTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$4.29 M
+$7.46 M+63.46%
June 30, 2023
Summary
- As of February 10, 2025, SGTX quarterly free cash flow is -$4.29 million, with the most recent change of +$7.46 million (+63.46%) on June 30, 2023.
- Over the past year, SGTX quarterly FCF has increased by +$10.60 million (+71.16%).
Performance
SGTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$33.28 M
+$10.60 M+24.15%
June 30, 2023
Summary
- As of February 10, 2025, SGTX TTM free cash flow is -$33.28 million, with the most recent change of +$10.60 million (+24.15%) on June 30, 2023.
- Over the past year, SGTX TTM FCF has increased by +$42.07 million (+55.83%).
Performance
SGTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SGTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.2% | +71.2% | +55.8% |
| 3 y3 years | -1.4% | +73.8% | -4.8% |
| 5 y5 years | -241.8% | - | - |
SGTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.3% | at high | +363.0% | at high | +141.1% |
| 5 y | 5-year | +1.4% | +54.3% | at high | +434.6% | +116.2% | +141.1% |
| alltime | all time | -241.8% | +54.3% | at high | +434.6% | +116.2% | +141.1% |
Sigilon Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$4.29 M(-63.5%) | -$33.28 M(-24.1%) |
| Mar 2023 | - | -$11.75 M(+62.3%) | -$43.88 M(-15.6%) |
| Dec 2022 | -$52.01 M(-35.2%) | -$7.24 M(-27.5%) | -$52.01 M(-16.7%) |
| Sep 2022 | - | -$9.99 M(-32.9%) | -$62.45 M(-17.1%) |
| Jun 2022 | - | -$14.89 M(-25.1%) | -$75.36 M(-2.3%) |
| Mar 2022 | - | -$19.89 M(+12.5%) | -$77.16 M(-3.8%) |
| Dec 2021 | -$80.24 M | -$17.68 M(-22.8%) | -$80.24 M(+0.1%) |
| Sep 2021 | - | -$22.90 M(+37.2%) | -$80.18 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$16.69 M(-27.3%) | -$70.51 M(+0.5%) |
| Mar 2021 | - | -$22.96 M(+30.3%) | -$70.19 M(+12.1%) |
| Dec 2020 | -$62.62 M(+22.1%) | -$17.62 M(+33.1%) | -$62.62 M(+39.1%) |
| Sep 2020 | - | -$13.24 M(-19.2%) | -$45.00 M(+41.7%) |
| Jun 2020 | - | -$16.37 M(+6.4%) | -$31.77 M(+106.4%) |
| Mar 2020 | - | -$15.39 M | -$15.39 M |
| Dec 2019 | -$51.28 M(-239.8%) | - | - |
| Dec 2018 | $36.68 M | - | - |
FAQ
- What is Sigilon Therapeutics annual free cash flow?
- What is the all time high annual FCF for Sigilon Therapeutics?
- What is Sigilon Therapeutics annual FCF year-on-year change?
- What is Sigilon Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Sigilon Therapeutics?
- What is Sigilon Therapeutics quarterly FCF year-on-year change?
- What is Sigilon Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Sigilon Therapeutics?
- What is Sigilon Therapeutics TTM FCF year-on-year change?
What is Sigilon Therapeutics annual free cash flow?
The current annual FCF of SGTX is -$52.01 M
What is the all time high annual FCF for Sigilon Therapeutics?
Sigilon Therapeutics all-time high annual free cash flow is $36.68 M
What is Sigilon Therapeutics annual FCF year-on-year change?
Over the past year, SGTX annual free cash flow has changed by +$28.23 M (+35.18%)
What is Sigilon Therapeutics quarterly free cash flow?
The current quarterly FCF of SGTX is -$4.29 M
What is the all time high quarterly FCF for Sigilon Therapeutics?
Sigilon Therapeutics all-time high quarterly free cash flow is -$4.29 M
What is Sigilon Therapeutics quarterly FCF year-on-year change?
Over the past year, SGTX quarterly free cash flow has changed by +$10.60 M (+71.16%)
What is Sigilon Therapeutics TTM free cash flow?
The current TTM FCF of SGTX is -$33.28 M
What is the all time high TTM FCF for Sigilon Therapeutics?
Sigilon Therapeutics all-time high TTM free cash flow is -$15.39 M
What is Sigilon Therapeutics TTM FCF year-on-year change?
Over the past year, SGTX TTM free cash flow has changed by +$42.07 M (+55.83%)